Lauren Morris - Medpace Holdings Associate Relations

MEDP Stock  USD 389.27  0.92  0.24%   

Insider

Lauren Morris is Associate Relations of Medpace Holdings
Phone513 579 9911
Webhttps://www.medpace.com

Medpace Holdings Management Efficiency

The company has return on total asset (ROA) of 0.1389 % which means that it generated a profit of $0.1389 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.6135 %, meaning that it created $0.6135 on every $100 dollars invested by stockholders. Medpace Holdings' management efficiency ratios could be used to measure how well Medpace Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 142.12 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Medpace Holdings has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Medpace Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Medpace Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medpace Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medpace to invest in growth at high rates of return. When we think about Medpace Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Michael MBANatera Inc
44
Olesya CPANatera Inc
N/A
John AbbottCastle Biosciences
N/A
Camilla ZuckeroCastle Biosciences
N/A
Rishi KackerNatera Inc
N/A
Eric EvansNatera Inc
N/A
Marica GrskovicCaredx Inc
N/A
Marcel KonradCaredx Inc
48
Pamela WongMyriad Genetics
56
Clivetty MartinezMyriad Genetics
N/A
Nicole LambertMyriad Genetics
50
Jonathan MEngNatera Inc
51
Dale MuzzeyMyriad Genetics
44
Andy AmentGuardant Health
N/A
Michael BellGuardant Health
55
Douglas JonesNeogen
54
Sasha MBACaredx Inc
38
Domitille BigotMettler Toledo International
48
Thomas TheuringerQiagen NV
N/A
Julie MannNeogen
59
RN RNCastle Biosciences
56
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company was founded in 1992 and is based in Cincinnati, Ohio. Medpace Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5000 people. Medpace Holdings (MEDP) is traded on NASDAQ Exchange in USA. It is located in 5375 Medpace Way, Cincinnati, OH, United States, 45227 and employs 5,800 people. Medpace Holdings is listed under Business Services category by Fama And French industry classification.

Management Performance

Medpace Holdings Leadership Team

Elected by the shareholders, the Medpace Holdings' board of directors comprises two types of representatives: Medpace Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medpace. The board's role is to monitor Medpace Holdings' management team and ensure that shareholders' interests are well served. Medpace Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medpace Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Susan Burwig, Senior Vice President - Operations
Kevin Brady, CFO Treasurer
Brandon Ebken, Chief Officer
August MD, Chairman CEO
Stephen JD, General Officer
Stephen Ewald, General Counsel, Corporate Secretary
Todd Meyers, Vice Marketing
Reinilde MD, Chief Department
Weimin MS, VP Biometrics
Daniel OLeary, VP Department
John MBA, Senior Unit
MA BSN, Executive Operations
CPA BBA, President
Lauren Morris, Associate Relations

Medpace Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medpace Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Medpace Holdings Investors Sentiment

The influence of Medpace Holdings' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Medpace. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Medpace Holdings' public news can be used to forecast risks associated with an investment in Medpace. The trend in average sentiment can be used to explain how an investor holding Medpace can time the market purely based on public headlines and social activities around Medpace Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Medpace Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Medpace Holdings' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Medpace Holdings' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Medpace Holdings.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medpace Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medpace Holdings' short interest history, or implied volatility extrapolated from Medpace Holdings options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medpace Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medpace Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medpace Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Medpace Holdings Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.
Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Medpace Stock analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.